HALL LAURIE J TRUSTEE - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.

Quarter-by-quarter ownership
HALL LAURIE J TRUSTEE ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$1
-99.9%
1350.0%0.00%
Q3 2022$1,0000.0%135
-32.5%
0.00%
Q2 2022$1,0000.0%2000.0%0.00%
Q1 2022$1,0000.0%2000.0%0.00%
Q4 2021$1,000
-50.0%
2000.0%0.00%
-100.0%
Q3 2021$2,000
-71.4%
200
-37.5%
0.00%
-66.7%
Q2 2021$7,000
-22.2%
3200.0%0.00%0.0%
Q1 2021$9,000
+12.5%
3200.0%0.00%0.0%
Q4 2020$8,0000.0%320
+45.5%
0.00%
-25.0%
Q3 2020$8,000
-20.0%
220
+29.4%
0.00%
-20.0%
Q4 2019$10,000
+150.0%
170
+70.0%
0.01%
+150.0%
Q3 2019$4,000
+33.3%
100
+42.9%
0.00%0.0%
Q2 2019$3,0000.0%700.0%0.00%0.0%
Q1 2019$3,0000.0%700.0%0.00%0.0%
Q4 2018$3,000
-25.0%
70
-12.5%
0.00%0.0%
Q3 2018$4,000
+33.3%
800.0%0.00%0.0%
Q2 2018$3,000
-78.6%
80
-57.9%
0.00%
-77.8%
Q1 2018$14,000
+7.7%
1900.0%0.01%
+28.6%
Q4 2017$13,000
-99.9%
190
-32.1%
0.01%
-22.2%
Q3 2017$14,034,000
+8.3%
2800.0%0.01%
+12.5%
Q2 2017$12,958,000
+29.7%
2800.0%0.01%
+33.3%
Q1 2017$9,988,0002800.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2018
NameSharesValueWeighting ↓
Boxer Capital, LLC 1,275,000$45,020,0009.84%
Aviva Holdings Ltd. 340,100$12,009,0005.60%
Aisling Capital LLC 837,125$29,559,0005.38%
RA Capital Management 704,701$24,883,0003.05%
Rhenman & Partners Asset Management AB 543,347$19,186,0003.04%
BB BIOTECH AG 1,408,542$49,736,0001.63%
Antipodean Advisors LLC 91,000$3,213,0001.57%
Iguana Healthcare Management, LLC 75,000$2,648,0001.31%
Crawford Lake Capital Management, LLC 93,551$3,303,0001.31%
FT Options LLC 22,834$806,0001.06%
View complete list of ESPERION THERAPEUTICS INC NE shareholders